Female exhibited severe cognitive impairment in type 2 diabetes mellitus mice

Life Sciences

Volumn 86, Issue 17-18, 2010, Pages 638-645

  Sakata, Akiko ^a   Mogi, Masaki ^a   Iwanami, Jun ^a   Tsukuda, Kana ^a   Min, Li Juan ^a   Jing, Fei ^a   Iwai, Masaru ^a   Ito, Masaharu ^a   Horiuchi, Masatsugu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cognitive impairment; Estradiol; Hyperinsulinemia; Oxidative stress; Passive avoidance test; PPAR gamma; Sex difference; The Morris water maze test; Type 2 diabetes mellitus

Indexed keywords

ESTRADIOL; ESTROGEN; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MAZE TEST; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEX DIFFERENCE; TASK PERFORMANCE; ANIMAL; AVOIDANCE BEHAVIOR; BLOOD; BRAIN; C57BL MOUSE; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; HOSPITALIZATION; METABOLISM;

MUS;

ANIMALS; AVOIDANCE LEARNING; BRAIN; COGNITION DISORDERS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; INSULIN; INSULIN RESISTANCE; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SUPEROXIDES;

EID: 77951245392     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.03.003     Document Type: Article

References (31)

1. Awad N., Gagnon M., Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. Journal of Clinical Experimental Neuropsychology 2004, 26(8):1044-1080.
2. Awasthi H, Tota S, Hanif K, Nath C, Shukla R. Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow. Life Science 86 (3-4), 87-94, 2010.
3. Biessels G.J., Gispen W.H. The impact of diabetes on cognition: what can be learned from rodent models?. Neurobiology of Aging 2005, 26(Suppl 1):36-41.
4. Chui M.H., Greenwood C.E. Antioxidant vitamins reduce acute meal-induced memory deficits in adults with type 2 diabetes. Nutrition Research 2008, 28(7):423-429.
5. Gregg E.W., Yaffe K., Cauley J.A., Rolka D.B., Blackwell T.L., Narayan K.M., Cummings S.R. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Archives of Internal Medicine 2000, 160(2):174-180.
6. Hosomi N., Nishiyama A., Ban C.R., Naya T., Takahashi T., Kohno M., Koziol J.A. Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia. Neuroscience 2005, 134(1):225-231.
7. Inaba S., Iwai M., Furuno M., Tomono Y., Kanno H., Senba I., Okayama H., Mogi M., Higaki J., Horiuchi M. Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice. Hypertension 2009, 53(2):356-362.
8. Kalmijn S., Feskens E.J., Launer L.J., Kromhout D. Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 1996, 27(12):2230-2235.
9. Kamal A., Biessels G.J., Duis S.E., Gispen W.H. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia 2000, 43(4):500-506.
10. Kolbeck R.C., She Z.W., Callahan L.A., Nosek T.M. Increased superoxide production during fatigue in the perfused rat diaphragm. American Journal of Respiratory and Critical Care Medicine 1997, 156(1):140-145.
11. Kumar P., Kaundal R.K., More S., Sharma S.S. Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease. Behavioural Brain Research 2009, 197(2):398-403.
12. Kumari R, Willing LB, Patel SD, Krady JK, Zavadoski WJ, Gibbs EM, Vannucci SJ, Simpson IA. The PPAR-gamma agonist, darglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob/ob mouse. Journal of Cerebral Blood Flow and Metabolism 30 (2), 352-360, 2010.
13. Li Z.G., Zhang W., Grunberger G., Sima A.A. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Research 2002, 946(2):221-231.
14. Lupien S.B., Bluhm E.J., Ishii D.N. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats. Journal of Neuroscience Research 2003, 74(4):512-523.
15. Matyka K., Evans M., Lomas J., Cranston I., Macdonald I., Amiel S.A. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997, 20(2):135-141.
16. Mogi M., Li J.M., Iwanami J., Min L.J., Tsukuda K., Iwai M., Horiuchi M. Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension 2006, 48(1):141-148.
17. Nagae A., Fujita M., Kawarazaki H., Matsui H., Ando K., Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation 2009, 119(7):978-986.
18. Oliveira-Sales E.B., Nishi E.E., Carillo B.A., Boim M.A., Dolnikoff M.S., Bergamaschi C.T., Campos R.R. Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. American Journal of Hypertension 2009, 22(5):484-492.
19. Pancani T., Phelps J.T., Searcy J.L., Kilgore M.W., Chen K.C., Porter N.M., Thibault O. Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons. Journal of Neurochemistry 2009, 109(6):1800-1811.
20. Pasquier F., Boulogne A., Leys D., Fontaine P. Diabetes mellitus and dementia. Diabetes & Metabolism 2006, 32(5 Pt 1):403-414.
21. Pathan A.R., Gaikwad A.B., Viswanad B., Ramarao P. Rosiglitazone attenuates the cognitive deficits induced by high fat diet feeding in rats. European Journal of Pharmacology 2008, 589(1-3):176-179.
22. Shimazu T., Inoue I., Araki N., Asano Y., Sawada M., Furuya D., Nagoya H., Greenberg J.H. A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 2005, 36(2):353-359.
23. Singh M., Meyer E.M., Millard W.J., Simpkins J.W. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Research 1994, 644(2):305-312.
24. Stolk R.P., Breteler M.M., Ott A., Pols H.A., Lamberts S.W., Grobbee D.E., Hofman A. Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care 1997, 20(5):792-795.
25. Sundararajan S., Gamboa J.L., Victor N.A., Wanderi E.W., Lust W.D., Landreth G.E. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 2005, 130(3):685-696.
26. Tsukuda K., Mogi M., Li J.M., Iwanami J., Min L.J., Sakata A., Fujita T., Iwai M., Horiuchi M. Amelioration of cognitive impairment in the type-2 diabetic mouse by the angiotensin II type-1 receptor blocker candesartan. Hypertension 2007, 50(6):1099-1105.
27. Walther T., Olah L., Harms C., Maul B., Bader M., Hortnagl H., Schultheiss H.P., Mies G. Ischemic injury in experimental stroke depends on angiotensin II. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2002, 16(2):169-176.
28. Watson G.S., Craft S. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis. Journal of the Neurological Sciences 2006, 245(1-2):21-33.
29. Whitmer R.A., Gunderson E.P., Barrett-Connor E., Quesenberry C.P., Yaffe K. Obesity in middle age and future risk of dementia: a 27year longitudinal population based study. BMJ 2005, 330(7504):1360.
30. Yaffe K., Blackwell T., Kanaya A.M., Davidowitz N., Barrett-Connor E., Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004, 63(4):658-663.
31. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414(6865):782-787.